Bayer-PCF Darolutamide Challenge Awards
Funding Amount
Varies
Deadline
Rolling / Open
Grant Type
foundation
Overview
Bayer-PCF Darolutamide Challenge Awards
Overview: Sponsored awards supporting research on darolutamide, an androgen receptor antagonist, in combination with other therapies and in vulnerable populations.
Focus Areas:
Example Projects (2023):
1. Darolutamide to Augment Radiotheranostic Therapy in Biochemically Recurrent Prostate Cancer (DART-BCR) (Harvard/Dana-Farber & Beth Israel Deaconess)
2. Darostep: Evaluating Step Counts as a Biomarker and its Relationship on Treatment Outcomes in Vulnerable Patients (University of Chicago)
Contact:
Prostate Cancer Foundation
1250 Fourth Street
Santa Monica, CA 90401
Phone: 1.800.757.CURE (2873)
Email: [email protected]
Focus Areas & Funding Uses
Fields of Work
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Alaska Run for Women Grants
Amount
Varies
Deadline
August 15, 2026
SBIR Innovative Molecular Analysis Technology (IMAT) Development for Cancer Research and Clinical Care
Amount
Varies
Deadline
Rolling / Open
ACC Mini Grants - Cancer Prevention
Amount
$3,500 - $5,500
Deadline
Rolling / Open
ACP Tobacco Prevention Grants (Mini Grants)
Amount
$3,500 - $5,500
Deadline
Rolling / Open
ACP Cancer Transportation Grants
Amount
$3,500
Deadline
Rolling / Open
Advanced Clinical Research Award - Breast Cancer Research Grant
Conquer Cancer Foundation
Amount
Up to US $450,000
Deadline
Rolling / Open
Ready to apply for Bayer-PCF Darolutamide Challenge Awards?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.